









Markets
/
Stocks
/
nasdaq-cbll
/

CeriBell Inc

CBLL

20.150USD

+0.810+4.19%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

746.53MMarket Cap

LossP/E TTM



CeriBell Inc

20.150

+0.810+4.19%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of CeriBell Inc

Currency: USD Updated: 2026-02-06

Key Insights

CeriBell Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 57 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 28.14.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

CeriBell Inc's Score

Industry at a Glance

Industry Ranking

57 / 205

Overall Ranking

161 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

CeriBell Inc Highlights

StrengthsRisks

CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 152.47% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 65.44M.

Fairly Valued

The company’s latest PE is -14.32, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 30.92M shares, decreasing 0.09% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 2.34K shares of this stock.

Analyst Rating

Based on 8 analysts

Strong Buy

Current Rating

28.143

Target Price

+45.52%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of CeriBell Inc is 7.25, ranking 96 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 22.59M, representing a year-over-year increase of 31.37%, while its net profit experienced a year-over-year increase of 29.26%.

Score

Industry at a Glance

Previous score

7.25

Change



Financials

8.15

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.45

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

5.57

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.91

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.20

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

CeriBell Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of CeriBell Inc is 7.26, ranking 102 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -14.32, which is -43.41% below the recent high of -8.11 and -98.67% above the recent low of -28.46.

Score

Industry at a Glance

Previous score

7.26

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 57/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of CeriBell Inc is 9.25, ranking 3 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 29.00, with a high of 32.00 and a low of 17.00.

Score

Industry at a Glance

Previous score

9.25

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 8 analysts

Strong Buy

Current Rating

28.143

Target Price

+45.52%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

CeriBell Inc

CBLL

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of CeriBell Inc is 6.76, ranking 87 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 23.39 and the support level at 17.84, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.34

Change

0.42

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.705

Neutral

RSI(14)

43.529

Neutral

STOCH(KDJ)(9,3,3)

25.200

Buy

ATR(14)

0.956

High Vlolatility

CCI(14)

-100.521

Sell

Williams %R

66.504

Sell

TRIX(12,20)

-0.236

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

20.068

Buy

MA10

20.589

Sell

MA20

21.588

Sell

MA50

20.885

Sell

MA100

16.653

Buy

MA200

16.040

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of CeriBell Inc is 7.00, ranking 80 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 84.91%, representing a quarter-over-quarter decrease of 0.14%. The largest institutional shareholder is The Vanguard, holding a total of 1.51M shares, representing 4.06% of shares outstanding, with 111.75% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Fidelity Management & Research Company LLC

4.31M

-8.04%

TPG Capital, L.P.

3.97M

Longitude Capital Management Co., LLC

2.48M

Global Value Investment Portfolio Management Pte. Ltd.

2.37M

Red Tree Management, LLC

2.21M

Parvizi (Josef)

2.09M

+0.32%

Ally Bridge Group (HK) Limited

1.69M

-30.72%

BlackRock Institutional Trust Company, N.A.

1.52M

+10.70%

The Vanguard Group, Inc.

Star Investors

1.47M

+11.09%

Chao (Xingjuan)

1.10M

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of CeriBell Inc is 5.08, ranking 88 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.